4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-006272
See Remarks sold 15,093 shares at an average $14.84 ($223,965)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schwartz Jonathan David See Remarks | 2024-05-17 | Sale | −2,754 | $23.35 | $64,306 | 169,659 | D: show line 1 in the form |
| Schwartz Jonathan David See Remarks | 2024-08-16 | Sale | −2,710 | $18.50 | $50,135 | 166,949 | D: show line 2 in the form |
| Schwartz Jonathan David See Remarks | 2024-11-21 | Sale | −3,097 | $13.05 | $40,416 | 163,852 | D: show line 3 in the form |
| Schwartz Jonathan David See Remarks | 2025-02-25 | Sale | −6,532 | $10.58 | $69,109 | 237,638 | D: show line 4 in the form |
| Open-market sales · 15,093 sh · avg $14.84 · $223,965 | |||||||
Loading xslF345X05/form4.xml…